News in the Life Sciences Industry

STOCKHOLM, Feb. 28, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that data from its Phase II HORIZON study and Phase I/II ANCHOR study evaluating the company's novel candidate melflufen, a peptide-conjugated alkylator belonging to the novel class of peptidase... Read more ››

COPENHAGEN, Denmark, Feb. 27, 2019 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today releases its Annual Report for the financial year 2018.

OSLO, Norway, Feb. 27, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2018. A presentation by the company's senior management team will take place today in Oslo at 08:30 CET, see details below.

BOSTON and STOCKHOLM, Feb. 27, 2019 /PRNewswire/ -- Aprea Therapeutics, a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein, today announced that funds managed by Janus Henderson Investors joined its Series C financing as a new... Read more ››

STOCKHOLM, Feb. 26, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST), a leader in precision radiation medicine, has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as one of the Read more ››

STOCKHOLM, Feb. 26, 2019 /PRNewswire/ -- Oncoinvent is pleased to announce that the Oslo University Hospital and Oncoinvent have each been awarded Innovation Funding to develop Radspherin® as a treatment for colorectal cancer patients suffering from peritoneal carcinomatosis. The two awards... Read more ››

LINKÖPING, Sweden, Feb. 26, 2019 /PRNewswire/ -- The international medical imaging IT and cybersecurity company Sectra (STO: SECT... Read more ››